EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum endocan levels in non-ST segment elevation myocardial infarction patients

Adem Melekoglu, Alp Giray Aydin, Uğur Kahveci, Nazmiye Ozcan, Serkan Ceritli, Zeynep Mine Yalcinkaya Kara, Hakan Kilci, Ertugrul Altinbilek, Derya Ozturk

Frontiers in Cardiovascular Medicine · 03.06.2026 · 13

DOI: 10.3389/fcvm.2026.1783106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 03.06.2026. Verfasst von Adem Melekoglu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Sisli Hamidiye Etfal Education and Research Hospital, Emergency Medicine, İstanbul, Türkiye. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Endothelial dysfunction and inflammation play a key role in the pathophysiology of acute coronary syndrome (ACS). Endocan has emerged as a novel biomarker reflecting endothelial activation.

Objective

To investigate serum endocan levels in patients with non–ST-segment elevation myocardial infarction (NSTEMI) and their association with coronary stenosis severity.

Methods

This prospective observational study included 81 NSTEMI patients undergoing coronary angiography. Patients were classified into clinically significant coronary stenosis and non-significant coronary stenosis groups. Serum endocan levels were measured at admission.

Results

Patients who underwent coronary angiography ( n = 81) were divided into two groups as those with clinically significant coronary stenosis ( n = 40) and non-significant coronary stenosis ( n = 41). Serum endocan levels were significantly higher in the group with clinically significant coronary stenosis ( p < 0.001). Mean age and body mass index (BMI) were higher and statistically significant in the group with clinically significant coronary stenosis ( p = 0.038, p = 0.042). Inflammation parameters C-reactive protein (CRP), White Blood Cell (WBC) and Neutrophil Lymphocyte ratio (NLR) were higher in the group with clinically significant coronary stenosis ( p < 0.001, p = 0.011, p = 0.038). In multivariate logistic regression analysis, endocan ( p < 0.001, 95% CI: 1.010–1.035), BMI ( p = 0.020, 95% CI: 1.070–2.237), and CRP ( p = 0.039, 95% CI: 1.003–1.099) were independently associated with clinically significant coronary stenosis. In Receiver operating curve (ROC) analysis performed to discriminate between patients with and without clinically significant coronary stenosis, the endocan cut-off value was determined as > 393.1 ng/L [ p < 0.001, The Area Under the Curve (AUC) = 0.826, 95% CI = 0.732–0.919, Likelihood Ratio + = 7.65, LR - = 0.28].

Conclusion

Endocan levels are elevated in NSTEMI patients with clinically significant coronary stenosis and may reflect endothelial dysfunction and atherosclerotic burden.

Schlagwörter

Stichwörter der Autor:innen

NSTEMIcoronary stenosisendocanendothelial dysfunctioninflammation

Autor:innen und Institutionen

  • Sisli Hamidiye Etfal Education and Research Hospital, Emergency Medicine, İstanbul, Türkiye.
  • Department of Emergency Medicine, Ministry of Health Eskişehir City Hospital, Eskişehir, Turkiye.
  • Emergency Department, University of Health Sciences Gulhane Training and Research Hospital, Ankara, Turkiye.
  • Department of Biochemistry, Sisli Hamidiye Etfal Education and Research Hospital, Istanbul, Turkiye.
  • Department of Cardiology, Sisli Hamidiye Etfal Education and Research Hospital, Istanbul, Turkiye.

Zitieren

APA

Melekoglu, A., Aydin, A. G., Kahveci, U., Ozcan, N., Ceritli, S., Kara, Z. M. Y., Kilci, H., Altinbilek, E., & Ozturk, D. (2026). Serum endocan levels in non-ST segment elevation myocardial infarction patients. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1783106

Vancouver

Melekoglu A, Aydin AG, Kahveci U, Ozcan N, Ceritli S, Kara ZMY, et al. Serum endocan levels in non-ST segment elevation myocardial infarction patients. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1783106

BibTeX
@article{Melekoglu2026,
  author = {Melekoglu, Adem and Aydin, Alp Giray and Kahveci, Uğur and Ozcan, Nazmiye and Ceritli, Serkan and Kara, Zeynep Mine Yalcinkaya and Kilci, Hakan and Altinbilek, Ertugrul and Ozturk, Derya},
  title = {Serum endocan levels in non-ST segment elevation myocardial infarction patients},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1783106}
}
Kostenlos starten →